Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 New Entrants companies in Nicotinamide mononucleotide
by Most Patent Filing In 1 Year in the world in 2019

The Nicotinamide mononucleotide top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Patent Filing In 1 Year Nicotinamide mononucleotide New Entrants in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Nicotinamide mononucleotide ("NMN", "NAMN", and "β-NMN") is a nucleotide derived from ribose and nicotinamide. Like nicotinamide riboside, NMN is a derivative of niacin, and humans have enzymes that can use NMN to generate nicotinamide adenine dinucleotide (NADH).
#
Company Name
Region
Tech Topics
Total
1
New Mexico, United States
Patent: 10
2
Tokyo, Japan
Patent: 7
3
Minnesota, United States
Patent: 4
4
Massachusetts, United States
Health care,Fertility
Patent: 3
5
Ontario, Canada
Patent: 3
6
Jiangsu Sheng, China
Patent: 2
7
Newcastle upon Tyne, United Kingdom
Patent: 1
8
Jiangsu Sheng, China
Academic Training,Educational institution,Graduate degree,
...[+2]
Patent: 1
9
China
Patent: 1
10
Guangdong Sheng, China
Patent: 1
Page generation time: Dec 13 2025